These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Drug resistance mutations and outcome of second-line treatment in patients with first-line protease inhibitor failure on nelfinavir-containing HAART. Røge BT; Katzenstein TL; Nielsen HL; Gerstoft J HIV Med; 2003 Jan; 4(1):38-47. PubMed ID: 12534958 [TBL] [Abstract][Full Text] [Related]
23. Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART. Hogg RS; Bangsberg DR; Lima VD; Alexander C; Bonner S; Yip B; Wood E; Dong WW; Montaner JS; Harrigan PR PLoS Med; 2006 Sep; 3(9):e356. PubMed ID: 16984218 [TBL] [Abstract][Full Text] [Related]
24. Performance of an in-house genotypic antiretroviral resistance assay in patients pretreated with multiple human immunodeficiency virus type 1 protease and reverse transcriptase inhibitors. Peduzzi C; Pierotti P; Venturi G; Romano L; Mazzotta F; Zazzi M J Clin Virol; 2002 Jul; 25(1):57-62. PubMed ID: 12126722 [TBL] [Abstract][Full Text] [Related]
25. Utility of repeat genotypic resistance testing and clinical response in patients with three class resistance and virologic treatment failure. Badri SM; Adeyemi OM; Max BE; Hota BN; Barker DE AIDS Patient Care STDS; 2007 Aug; 21(8):544-50. PubMed ID: 17711379 [TBL] [Abstract][Full Text] [Related]
26. HIV type-1 genotypic resistance profiles in vertically infected patients from Argentina reveal an association between K103N+L100I and L74V mutations. Aulicino PC; Rocco CA; Mecikovsky D; Bologna R; Mangano A; Sen L Antivir Ther; 2010; 15(4):641-50. PubMed ID: 20587857 [TBL] [Abstract][Full Text] [Related]
27. [HIV-1 genotypic resistance profiles in children failing highly active antiretroviral therapy]. Liu ZY; Wei HS; Zhao HX; Liu YN; Zhao Y; Han N; Cheng J; Zhang FJ Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(46):3292-4. PubMed ID: 18396628 [TBL] [Abstract][Full Text] [Related]
28. Genotypic resistance and HIV-1 subtype in Brazilian children on dual and triple combination therapy. Machado ES; Lambert JS; Watson DC; Afonso AO; da Cunha SM; Nogueira SA; Caride E; Oliveira RH; Sill AM; DeVico A; Tanuri A J Clin Virol; 2004 May; 30(1):24-31. PubMed ID: 15072750 [TBL] [Abstract][Full Text] [Related]
29. HIV-1 reverse transcriptase and protease resistance mutations selected during 16-72 weeks of therapy in isolates from antiretroviral therapy-experienced patients receiving abacavir/efavirenz/amprenavir in the CNA2007 study. Ait-Khaled M; Rakik A; Griffin P; Stone C; Richards N; Thomas D; Falloon J; Tisdale M; Antivir Ther; 2003 Apr; 8(2):111-20. PubMed ID: 12741623 [TBL] [Abstract][Full Text] [Related]
30. HIV-1 Drug Resistance Profiles for the HIV Protease and Reverse Transcriptase Gene in Patients Receiving Combination Therapy in Tehran, Iran. Sadeghi L; Lolaie M; Tabatabai RA; Bayanolhagh S; Taj L; Ahmadi NE; Abedinzadeh N; Vakili F; Ahmadi G; Mohraz M Infect Disord Drug Targets; 2018; 18(3):241-248. PubMed ID: 29663899 [TBL] [Abstract][Full Text] [Related]
31. Long-term analysis of the resistance development in HIV-1 positive patients treated with protease and reverse transcriptase inhibitors: correlation of the genotype and disease progression. Václavíková J; Weber J; Machala L; Reinis M; Linka M; Brůcková M; Vandasová J; Stanková M; Konvalinka J Acta Virol; 2005; 49(1):29-36. PubMed ID: 15929396 [TBL] [Abstract][Full Text] [Related]
32. Testing genotypic and phenotypic resistance in human immunodeficiency virus type 1 isolates of clade B and other clades from children failing antiretroviral therapy. Brindeiro PA; Brindeiro RM; Mortensen C; Hertogs K; De Vroey V; Rubini NP; Sion FS; De Sá CA; Machado DM; Succi RC; Tanuri A J Clin Microbiol; 2002 Dec; 40(12):4512-9. PubMed ID: 12454144 [TBL] [Abstract][Full Text] [Related]
33. Persistence of genotypic resistance to nelfinavir among women exposed to prophylactic antiretroviral therapy during pregnancy. Kakehasi FM; Tupinambás U; Cleto S; Aleixo A; Lin E; Melo VH; Aguiar RA; Pinto JA AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1515-20. PubMed ID: 18160009 [TBL] [Abstract][Full Text] [Related]
34. Baseline antiretroviral drug susceptibility influences treatment response in patients receiving saquinavir-enhancing therapy. Middleton T; Smith D; Larder B; Law M; Birch C HIV Clin Trials; 2001; 2(6):445-52. PubMed ID: 11742431 [TBL] [Abstract][Full Text] [Related]
35. Ultradeep sequencing of B and non-B HIV-1 subtypes: Viral diversity and drug resistance mutations before and after one month of antiretroviral therapy in naive patients. Epaulard O; Signori-Schmuck A; Larrat S; Kulkarni O; Blum MG; Fusillier K; Blanc M; Leclercq P; François O; Morand P J Clin Virol; 2017 Oct; 95():13-19. PubMed ID: 28830014 [TBL] [Abstract][Full Text] [Related]
36. Long-term suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug-resistant genotypes. Pariente N; Pernas M; de la Rosa R; Gómez-Mariano G; Fernández G; Rubio A; López M; Benito JM; López-Galíndez C; Leal M; Domingo E; Martinez MA; Mas A J Med Virol; 2004 Jul; 73(3):350-61. PubMed ID: 15170628 [TBL] [Abstract][Full Text] [Related]
37. Natural residues versus antiretroviral drug-selected mutations in HIV type 1 group O reverse transcriptase and protease related to virological drug failure in vivo. de Baar MP; Janssens W; de Ronde A; Fransen K; Colebunders R; Kestens L; van der Groen G; Goudsmit J AIDS Res Hum Retroviruses; 2000 Sep; 16(14):1385-94. PubMed ID: 11018858 [TBL] [Abstract][Full Text] [Related]
38. Drug resistant mutations detected by genotypic drug resistance testing in patients failing therapy in clade C HIV-1 infected individuals from India. Kandathil AJ; Kannangai R; Verghese VP; Pulimood SA; Rupali P; Sridharan G; Grant P; Pillay D; Abraham OC Indian J Med Microbiol; 2009; 27(3):231-6. PubMed ID: 19584504 [TBL] [Abstract][Full Text] [Related]
39. Analysis of HIV drug-resistant quasispecies in plasma, peripheral blood mononuclear cells and viral isolates from treatment-naive and HAART patients. Paolucci S; Baldanti F; Campanini G; Zavattoni M; Cattaneo E; Dossena L; Gerna G J Med Virol; 2001 Oct; 65(2):207-17. PubMed ID: 11536225 [TBL] [Abstract][Full Text] [Related]
40. High level of HIV-1 resistance in patients failing long-term first-line antiretroviral therapy in Mali. Fofana DB; Soulié C; Baldé A; Lambert-Niclot S; Sylla M; Ait-Arkoub Z; Diallo F; Sangaré B; Cissé M; Maïga IA; Fourati S; Koita O; Calvez V; Marcelin AG; Maïga AI J Antimicrob Chemother; 2014 Sep; 69(9):2531-5. PubMed ID: 24855120 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]